Home > News > Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?
September 13th, 2005
Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?
Nanotechnology is poised to enable advances that could be utilized to shave time and expense from multiple stages of the drug discovery and development efforts.
Ohio State University
National Cancer Institute
A glass fiber that brings light to a standstill: By coupling photons to atoms, light in a glass fiber can be slowed down to the speed of an express train; for a short while it can even be brought to a complete stop April 9th, 2015
Nanotechnology in Medical Devices Market is expected to reach $8.5 Billion by 2019 March 25th, 2015
Nanotechnology Enabled Drug Delivery to Influence Future Diagnosis and Treatments of Diseases March 21st, 2015
Nanocomposites Market Growth, Industry Outlook To 2020 by Grand View Research, Inc. March 21st, 2015
Optical resonance-based biosensors designed for medical applications April 18th, 2015
Nanocomposites Play Effective Role in Production of Smart Fibers April 18th, 2015
Novel nanoparticles could save soldiers' lives after explosions April 15th, 2015
Nanoparticles at specific temperature stimulate antitumor response: Dartmouth researchers identify precise heat to boost immune system against cancer tumors April 14th, 2015